Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors
Background Targeting epidermal growth factor receptor (EGFR) has become a strategic approach in cancer therapy, using various modalities including chimeric antigen receptor (CAR)-αβT cell therapies. Despite significant advancements in autologous CAR-αβT cell therapies in B-cell lymphoma, current cel...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Статья |
| Язык: | английский |
| Опубликовано: |
BMJ Publishing Group
2025-07-01
|
| Серии: | Journal for ImmunoTherapy of Cancer |
| Online-ссылка: | https://jitc.bmj.com/content/13/7/e010500.full |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|